Bellicum Pharmaceuticals (BLCM) News Today → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free BLCM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisEarningsOwnershipSocial MediaStock AnalysisEarningsOwnershipSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBellicum sells assets to MD Anderson, moves towards liquidationmsn.com - February 22 at 10:25 PMBellicum Pharmaceuticals Issues Super-Voting Share Privatelymsn.com - January 25 at 8:14 AMBellicum Pharmaceuticals Inc BLCMmorningstar.com - December 23 at 9:38 AMBellicum Pharmaceuticals Stock (OTC:BLCM), Short Interest Reportbenzinga.com - December 8 at 7:14 PMFutura Medical plc (FAMDF)finance.yahoo.com - October 27 at 12:10 AMBLCM - Bellicum Pharmaceuticals, Inc.finance.yahoo.com - July 13 at 6:56 PMBellicum Pharmaceuticals (NASDAQ: BLCM)fool.com - June 3 at 2:07 PMmarketbeat.com - May 8 at 12:13 PMmarketbeat.com - May 8 at 12:13 PMWhy Is Bellicum Pharmaceuticals (BLCM) Stock Up 75% Today?investorplace.com - May 8 at 9:08 AMWhy Digital Brands Group Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarketmsn.com - April 18 at 8:18 PMShort Volatility Alert: Bellicum Pharmabenzinga.com - April 18 at 10:17 AMBLCM Plummets on Stopping Trials of BPX-601 and BPX-603msn.com - March 15 at 3:54 PMWhy Bellicum Pharmaceuticals (BLCM) Stock Is Down 48%msn.com - March 15 at 3:54 PMBellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic Alternativesfinance.yahoo.com - March 14 at 6:54 PMmarketbeat.com - March 14 at 4:26 PMWhy Bellicum Pharmaceuticals Stock Is Plunging Todayfinance.yahoo.com - February 24 at 1:47 AMBellicum Presents Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO GU Cancers Symposiumfinance.yahoo.com - February 16 at 7:54 AMCORRECTION -- Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - January 31 at 8:11 PMBellicum Pharmaceuticals to Present Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO 2023 Genitourinary Cancers Symposiumfinance.yahoo.com - January 19 at 12:39 PMmarketbeat.com - January 6 at 2:59 PMBellicum Pharmaceuticals, Inc.: Bellicum Reports Third Quarter 2022 Financial Results and Provides Operational Updatefinanznachrichten.de - November 13 at 5:28 PMBellicum Reports Third Quarter 2022 Financial Results and Provides Operational Updatefinance.yahoo.com - November 10 at 8:16 PMBellicum Pharmaceuticals to Participate in the 2022 Cell & Gene Meeting on the Mesafinance.yahoo.com - October 4 at 10:57 AMBLCM Bellicum Pharmaceuticals, Inc.seekingalpha.com - September 15 at 7:27 PMBellicum Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 1 at 9:53 AMBellicum Pharmaceuticals (BLCM) Could Find Support Soon, Here's Why You Should Buy the Stock Nowfinance.yahoo.com - August 25 at 12:15 PMIs Immunocore (IMCR) Stock Outpacing Its Medical Peers This Year?finance.yahoo.com - August 18 at 1:03 PMBellicum Reports Second Quarter 2022 Financial Results and Provides Operational Updatefinance.yahoo.com - August 11 at 7:18 PMBellicum Pharmaceuticals GAAP EPS of -$0.25 beats by $0.42seekingalpha.com - May 13 at 2:26 AMBellicum Reports First Quarter 2022 Financial Results and Provides Operational Updatefinance.yahoo.com - May 13 at 2:26 AMBellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Updatefinance.yahoo.com - March 24 at 4:52 PMLadenburg Thalmann Initiates Coverage On Bellicum Pharmaceuticals with Buy Rating, Announces Price Target of $5benzinga.com - February 16 at 12:22 PMBellicum Pharmaceuticals Inc. BLCMstockhouse.com - January 28 at 9:07 PMBellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conferencefinance.yahoo.com - January 26 at 6:08 PMBellicum Regains Compliance with Nasdaq Continued Listing Requirementsfinance.yahoo.com - December 13 at 6:11 PMSumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021finance.yahoo.com - December 10 at 1:11 PMBellicum Secures $35M Via Equity Funding, Posts Interim Data From Early GoCAR-T Cancer Studiesmsn.com - December 7 at 4:48 AMBellicum Reports Positive Interim Data From Phase 1/2 GoCAR-T Trials - Quick Factsmarkets.businessinsider.com - December 6 at 12:45 PMBellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Private Placement Equity Financing Priced at Marketfinance.yahoo.com - December 6 at 7:44 AMK2 BioLabs hiring, expanding contract research offerings for biotech, pharma startupsbizjournals.com - December 2 at 6:56 PMBellicum Reports Third Quarter 2021 Financial Results and Provides Operational Updatefinance.yahoo.com - November 4 at 7:52 PMBellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment ...apnews.com - September 3 at 3:46 PMBellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Conferencefinance.yahoo.com - September 3 at 3:46 PMBellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety Switchfinance.yahoo.com - September 1 at 6:25 PMBellicum Pharmaceuticals: Q2 Earnings Snapshotsfgate.com - August 12 at 9:49 PMBellicum Reports Second Quarter 2021 Financial Results and Provides Operational Updatefinance.yahoo.com - August 12 at 4:49 PM Get Bellicum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Proof that the Musk/Bezos rivalry is about to hit a new level (Ad)Elon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats… Go here now for full story. BLCM Media Mentions By Week BLCM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCM News Sentiment▼0.340.39▲Average Medical News Sentiment BLCM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCM Articles This Week▼00▲BLCM Articles Average Week Get Bellicum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: 9 Meters Biopharma News Today Eiger BioPharmaceuticals News Today Windtree Therapeutics News Today Evofem Biosciences News Today Bellerophon Therapeutics News Today Better Therapeutics News Today Acorda Therapeutics News Today Akanda News Today Bone Biologics News Today Scinai Immunotherapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLCM) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellicum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.